LONDON, October 9, 2018 /PRNewswire/ --
- Cannabis Europa Paris will take place on 8th February 2019 at La Maison de la Chimie
- Cannabis Europa London will take place on 24th and 25th June 2019
- Cannabis Europa solves uniquely European issues facing the medical cannabis industry
Cannabis Europa Paris - Friday 8th February 2019
Cannabis Europa Paris will connect leaders of the medical cannabis industry with European policy-makers, patients and researchers to support the growth of a responsible and accessible European medical cannabis industry.
Europe is poised to become the largest cannabis market in the world, with a forecasted medical cannabis market of over €55 billion by 2028. Encompassing more than 50 countries of different size, character and politics, the European market is significantly more complex than any other medical cannabis market.
Cannabis Europa Paris is focused on three key themes: the francophone markets, European leadership in policy-making and exploring the gap between pharmaceutical and medical cannabis. The conference will provide practical responses to the obstacles in European medical cannabis adoption, examine the pharmaceutical industry's distinct role in Europe's cannabis markets and offer insight into what drives Europe's regulatory process.
The conference will be held at the Maison de la Chimie - 'The House of Chemistry' - moments away from France's National Assembly, on the 8th of February. Appropriately, this historic venue is home to the Fondation de la Chimie, an organisation that facilitates the sharing of knowledge and expertise between scientific bodies, industry and the general public on a worldwide basis.
Cannabis Europa London - Monday 24th and Tuesday 25th June 2019
Cannabis Europa London builds on the momentum of the inaugural Cannabis Europa conference in May 2018. The event saw over 500 speakers and attendees from around the world come together in London's Barbican Centre to help shape Europe's fledgling yet rapidly-evolving medical cannabis industry.
Next year Cannabis Europa's flagship conference will return to London on the 24th and 25th of June. Cannabis Europa London will offer unrivalled access to the world's most influential, inspirational and forward-thinking figures of the industry, and serve as the foremost arena to share knowledge and shape the future of medical cannabis in Europe.
Alastair Moore, Managing Director of Cannabis Europa said:
"I'm delighted to announce Cannabis Europa Paris and London, following the overwhelming success of our inaugural conference.
"The European cannabis industry is developing at a remarkable pace. In just the last few months, Malta has begun sales of medical cannabis, the UK has expanded access to cannabis-based medicines, and France has launched a review of their medical cannabis system.
"Cannabis Europa brings together the best from policy, industry and academia to shine a light on the promising, yet often complex and confusing European landscape, and to help businesses succeed in this unique market."
For more information on Cannabis Europa, visit: http://www.cannabis-europa.com
About Cannabis Europa:
Cannabis Europa produces thought-provoking, uniquely European conferences to promote a responsible and accessible European medical cannabis industry. Cannabis Europa is a joint venture of Hanway Associates and Prohibition Partners.
Notes to editors:
- European cannabis market predictions from The European Cannabis Report™ 3rd Edition, published by Prohibition Partners.
For press enquiries, contact Pierre-Yves Galléty: firstname.lastname@example.org | +44-783-515-6285
SOURCE Cannabis Europa